Back to GetFilings.com



 

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 


 

FORM 10-Q

 

ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2002

 

OR

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from          to          

 

Commission File Number: 0-30822

 


 

SYNAVANT Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

22-2940965

(State of Incorporation)

 

(I.R.S. Employer Identification No.)

 

 

 

3445 Peachtree Road NE, Suite 1400

 

 

Atlanta, GA

 

30326

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code (404) 841-4000

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ý No o

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

 

Title of Class

 

Shares Outstanding at July 31, 2002

 

Common Stock, par value $.01 per share

 

15,160,567 Shares

 

 

 



 

SYNAVANT Inc.

FORM 10-Q

FOR THE QUARTER ENDED JUNE 30, 2002

 

 

INDEX

 

PART I.

FINANCIAL INFORMATION

 

 

ITEM 1.

FINANCIAL STATEMENTS

 

 

 

Condensed Consolidated Balance Sheets as of June 30, 2002 and December 31, 2001

 

 

 

Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2002 and 2001

 

 

 

Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2002 and 2001

 

 

 

Notes to Consolidated Financial Statements

 

 

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

 

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

 

PART II.

OTHER INFORMATION

 

 

ITEM 1.

LEGAL PROCEEDINGS

 

 

ITEM 2.

CHANGES IN SECURITIES AND USE OF PROCEEDS

 

 

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

 

 

ITEM 4.

SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

 

ITEM 5.

OTHER INFORMATION

 

 

ITEM 6.

EXHIBITS AND REPORTS ON FORM 8-K

 

 

SIGNATURES

 

2



 

PART I. FINANCIAL INFORMATION

 

ITEM I. FINANCIAL STATEMENTS

 

SYNAVANT Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollar amounts in thousands, except per share data)

 

 

 

June 30,
2002

 

December 31,
2001

 

 

 

(Unaudited)

 

(Audited)

 

ASSETS:

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

Cash and cash equivalents

 

$

11,782

 

$

9,578

 

Accounts receivable—net

 

39,581

 

39,574

 

Other receivables

 

223

 

209

 

Other current assets

 

5,804

 

6,113

 

TOTAL CURRENT ASSETS

 

57,390

 

55,474

 

 

 

 

 

 

 

Property, plant and equipment—net

 

12,138

 

11,210

 

Computer software—net

 

4,911

 

7,410

 

Goodwill—net

 

41,156

 

41,156

 

Long term notes receivable

 

1,000

 

1,000

 

Other assets

 

2,207

 

2,008

 

TOTAL LONG TERM ASSETS

 

61,412

 

62,784

 

TOTAL ASSETS

 

$

118,802

 

$

118,258

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY:

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

Accounts payable

 

$

9,229

 

$

9,516

 

Accrued restructuring

 

3,285

 

4,816

 

Accrued and other current liabilities

 

15,738

 

13,289

 

Accrued income taxes

 

3,231

 

1,885

 

Deferred revenues

 

9,249

 

8,388

 

TOTAL CURRENT LIABILITIES

 

40,732

 

37,894

 

 

 

 

 

 

 

Deferred taxes

 

430

 

421

 

Accrued liability due to former parent

 

9,000

 

9,000

 

Other liabilities

 

1,413

 

793

 

TOTAL LIABILITIES

 

$

51,575

 

$

48,108

 

 

 

 

 

 

 

Commitments and contingencies (see note 2)

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY:

 

 

 

 

 

Common stock, par value $.01, authorized 41,000,000 shares; 15,153,065 shares outstanding at June 30, 2002

 

152

 

150

 

Other stockholders’ equity

 

67,075

 

70,000

 

TOTAL STOCKHOLDERS’ EQUITY

 

67,227

 

70,150

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

 

$

118,802

 

$

118,258

 

 

See accompanying Notes to the Consolidated Financial Statements (unaudited).

 

3



 

SYNAVANT Inc.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(Dollar amounts in thousands, except per share data)

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

 

 

2002

 

2001

 

2002

 

2001

 

REVENUES:

 

 

 

 

 

 

 

 

 

Software fees

 

$

1,086

 

$

4,019

 

$

2,526

 

$

7,172

 

Software services

 

22,107

 

22,296

 

42,956

 

43,750

 

Interactive marketing

 

20,396

 

20,358

 

43,068

 

39,829

 

TOTAL REVENUES

 

43,589

 

46,673

 

88,550

 

90,751

 

 

 

 

 

 

 

 

 

 

 

OPERATING COSTS:

 

 

 

 

 

 

 

 

 

Software fees

 

807

 

2,321

 

1,534

 

4,573